STOCK TITAN

C.H. Robinson arranges up to $500M in RXO deal financing

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

C.H. Robinson Worldwide (CHRW) entered an agreement for up to $500 million in acquisition financing through a senior unsecured delayed-draw term loan facility tied to its planned acquisition of RXO. The loan may be drawn once, upon completion of the acquisition, and matures on its second anniversary. The agreement reduced commitments under a separate 364-day bridge facility by $500 million. Interest is, at the company’s option, Term SOFR plus 0.75%-1.375% or a base rate plus 0%-0.375%, depending on the company’s credit ratings.

The receivables facility has $750 million in total committed funding following a November 18, 2026 amendment: Bank of America’s commitment is $300 million and Wells Fargo’s is $450 million, with Wells Fargo becoming administrative agent. The scheduled purchase termination date was extended to November 17, 2028. Loan funding depends on completion of the RXO acquisition and other specified conditions. A net leverage covenant caps the ratio at 4.25 to 1.00 for the first four fiscal quarters after funding and 3.75 to 1.00 thereafter, with a step-up to 4.25 to 1.00 if the company elects a leverage holiday for a subsequent permitted acquisition.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Delayed-draw term loan facility Up to $500 million May be drawn in a single borrowing upon completion of the RXO acquisition.
Receivables facility commitments $750 million Total committed funding after the amendment.
Bank of America commitment $300 million Commitment under the receivables facility after the amendment.
Wells Fargo commitment $450 million Commitment under the receivables facility after the amendment.
Term SOFR margin 0.75%-1.375% Added to Term SOFR; margin depends on CHRW's credit ratings.
Base rate margin 0%-0.375% Added to the base rate; margin depends on CHRW's credit ratings.
Net leverage ratio covenant 4.25 to 1.00; 3.75 to 1.00 First four fiscal quarters after funding; thereafter, respectively.
Scheduled purchase termination date November 17, 2028 Receivables facility date following the amendment.
delayed draw term loan facility financial
"a senior unsecured delayed draw term loan facility"
A delayed draw term loan facility is a committed loan that a borrower can tap in one or more installments at specified future times after meeting agreed conditions, rather than receiving the full amount upfront. For investors it matters because it provides a ready source of cash that can change a company’s financial strength, leverage and interest costs when drawn—similar to having a reserved credit line you can use later, which affects liquidity and the risk profile of the business.
Term SOFR financial
"at Term SOFR plus a margin"
Term SOFR is a benchmark interest rate that reflects the cost of borrowing money over a specific period, based on actual transactions in the financial markets. It is used by lenders and borrowers to set the interest rates on loans and financial contracts, helping to ensure rates are fair and transparent. For investors, understanding term SOFR helps gauge borrowing costs and the overall direction of interest rates in the economy.
ticking fee financial
"pay a ticking fee on undrawn commitments"
A ticking fee is a charge that accrues over time when one party has committed to a deal but the transaction has not yet closed; it compensates the other side for the cost and risk of the delay. For investors, it matters because it raises the effective cost of a transaction and signals how long completion may take—like paying a small ongoing rent while waiting for a house sale to finish, which can affect returns and deal judgment.
net leverage ratio financial
"a covenant requiring the Company to maintain a net leverage ratio"
The net leverage ratio measures how much debt a company has compared to its available assets or earnings, after accounting for its cash and liquid assets. It helps investors understand how heavily a company relies on borrowed money to finance its operations and growth. A higher ratio indicates greater financial risk, while a lower ratio suggests a more cautious approach to borrowing.
receivables securitization facility technical
"which provides a receivables securitization facility"
material adverse effect technical
"the absence of a material adverse effect on RXO"
A material adverse effect is a significant negative change or event that substantially reduces a company’s business, financial condition, or future prospects — think of it like a sudden major engine failure that makes a car unreliable. Investors care because such an event can lower expected profits, trigger contract clauses (allowing counterparties to renegotiate or walk away), and prompt swift stock-price reassessment based on the higher risk and uncertainty.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much term-loan financing did CHRW arrange for the RXO acquisition?

CHRW's facility provides up to $500 million and may be drawn in a single borrowing when the RXO acquisition is completed. Proceeds may fund a portion of the acquisition and related transactions, fees and expenses. The loan matures on the second anniversary of the acquisition's completion.

What interest rates apply to CHRW's delayed-draw term loan?

The company may choose Term SOFR plus 0.75%-1.375% or a base rate plus 0%-0.375%. The applicable margin depends on CHRW's credit ratings from S&P and Moody's.

What changed in CHRW's receivables facility?

The facility has $750 million in total committed funding, comprising $300 million from Bank of America and $450 million from Wells Fargo. Wells Fargo became successor administrative agent, and the scheduled purchase termination date was extended to November 17, 2028.

What leverage limits apply to CHRW's term loan?

The covenant sets a maximum net leverage ratio of 4.25 to 1.00 as of the last day of each of the first four fiscal quarters after funding, then 3.75 to 1.00 thereafter. It permits a step-up to 4.25 to 1.00 in connection with a leverage holiday elected for a subsequent permitted acquisition.

What conditions apply before CHRW can draw the term loan?

Funding is subject to completion of the RXO acquisition substantially in accordance with the merger agreement, the absence of a material adverse effect on RXO, the accuracy of specified representations, delivery of a solvency certificate and repayment of RXO's existing asset-based revolving credit facility.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0001043277false00010432772026-11-182026-11-18
    
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report: November 18, 2026
(Date of earliest event reported)
CHR_Logomark_299CP_CMYK (003).jpg
C.H. ROBINSON WORLDWIDE, INC.
(Exact name of registrant as specified in its charter)

Commission File Number: 000-23189
Delaware41-1883630
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)

14701 Charlson Road
Eden Prairie, Minnesota 55347
(Address of principal executive offices, including zip code)

Registrant's telephone number, including area code: 952-937-8500

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.10 par valueCHRWNasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐




    
Item 1.01    Entry into a Material Definitive Agreement.

On November 19, 2026, C.H. Robinson Worldwide, Inc. (the “Company”) entered into a Delayed Draw Term Loan Credit Agreement (the “Term Loan Agreement”) with the lenders party thereto and U.S. Bank National Association, as administrative agent, in connection with the Company’s previously announced acquisition of RXO, Inc. (“RXO”) pursuant to the Agreement and Plan of Merger, dated as of October 4, 2026 (the “Merger Agreement” and such acquisition, the “RXO Acquisition”), and the related financing transactions. The Term Loan Agreement provides for a senior unsecured delayed draw term loan facility in an aggregate principal amount of up to $500 million, which may be drawn in a single borrowing on the date the RXO Acquisition is completed and which matures on the second anniversary of that date. The commitments terminate if the term loans are not drawn by the earliest of the availability period, which ends upon the earliest of the consummation of the RXO Acquisition without the funding of the term loans, the termination of the Merger Agreement by the Company, or five business days after the outside date under the Merger Agreement (as it may be extended pursuant to the terms thereof). The obligations under the Term Loan Agreement are guaranteed by certain of the Company’s material domestic subsidiaries. The proceeds of the term loans may be used to fund a portion of the RXO Acquisition and the related transactions and to pay related fees and expenses.
Loans under the Term Loan Agreement will bear interest, at the Company’s option, at Term SOFR plus a margin ranging from 0.75% to 1.375% or a base rate plus a margin ranging from 0% to 0.375%, in each case determined based on the Company’s credit ratings from S&P and Moody’s. The Company will also pay a ticking fee ranging from 0.07% to 0.15% per annum on undrawn commitments, accruing from the later of the effective date of the Term Loan Agreement and February 1, 2027. The loans may be prepaid at any time without premium or penalty, subject to customary breakage costs.
The funding of the term loans is subject only to limited conditions, including the consummation of the RXO Acquisition substantially in accordance with the Merger Agreement, the absence of a material adverse effect on RXO, the accuracy of specified representations and specified acquisition representations, the delivery of a solvency certificate and the repayment of RXO’s existing asset-based revolving credit facility. The Term Loan Agreement contains representations and warranties, covenants and events of default substantially similar to those in the Company’s existing revolving credit agreement with U.S. Bank National Association, as administrative agent, as amended, including a covenant requiring the Company to maintain a net leverage ratio of not more than 4.25 to 1.00 as of the last day of each of the first four fiscal quarters following the funding date (beginning with the fiscal quarter in which funding occurs) and not more than 3.75 to 1.00 thereafter, subject to a step-up to 4.25 to 1.00 in connection with a leverage holiday elected for a subsequent permitted acquisition. The foregoing description of the Term Loan Agreement is qualified in its entirety by reference to the full text of the Term Loan Agreement, which is filed as Exhibit 10.1 hereto.
As a result of the Company’s entry into the Term Loan Agreement, the commitments under the senior unsecured 364-day bridge facility provided for in the commitment letter, dated October 4, 2026, between the Company and Morgan Stanley Senior Funding, Inc., as previously disclosed in the Company’s Current Report on Form 8-K filed on October 5, 2026, were reduced by $500 million in accordance with the terms of such commitment letter.
On November 18, 2026, the Company also entered into the Seventh Amendment (the “RPA Amendment”) to its existing Receivables Purchase Agreement dated as of November 19, 2021, as amended February 1, 2022, July 7, 2022, November 7, 2023, October 14, 2024, August 12, 2025 and June 1, 2026 (the “RPA”), among the Company, as initial master servicer and performance guarantor, C.H. Robinson Receivables, LLC, a wholly-owned subsidiary of the Company and bankruptcy-remote entity (“CHRR”), as seller, Bank of America, N.A. (“BofA”) and Wells Fargo Bank, National Association (“Wells Fargo”), as committed purchasers and purchaser agents, and BofA, as administrative agent, which provides a receivables securitization facility (the “Facility”). The RPA Amendment, among other things, (i) provides for the assignment by BofA of its role as administrative agent under the RPA and the related transaction documents to Wells Fargo, as successor administrative agent, (ii) provides for a one-time, non-ratable repayment of a portion of BofA’s investment funded by a corresponding purchase by Wells Fargo, such that the commitments under the Facility are $300 million for BofA and $450 million for Wells Fargo, for total committed funding of $750 million, (iii) extends the scheduled purchase termination date of the Facility to November 17, 2028 and (iv) makes certain other changes, including updates to sanctions, anti-corruption, outbound investment and related provisions. In connection with the RPA Amendment, the Company and certain of its subsidiaries also entered into an Amended and Restated Performance Guaranty, a Second Amendment to the Receivables Sale Agreement and certain other ancillary documents.
The foregoing description of the RPA Amendment, the Amended and Restated Performance Guaranty and the Second Amendment to the Receivables Sale Agreement is qualified in its entirety by reference to the full text of the RPA Amendment, the Amended and Restated Performance Guaranty and the Second Amendment to the Receivables Sale Agreement, which are filed as Exhibits 10.2, 10.3 and 10.4 hereto. The Sixth Amendment to the RPA dated as of June 1, 2026 is filed as Exhibit 10.5 hereto.
Item 2.03    Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.

The discussion under Item 1.01 is incorporated herein by reference.




    
Item 9.01    Financial Statements and Exhibits.

(d)    Exhibits

NumberDescription
10.1*
Delayed Draw Term Loan Credit Agreement dated as of November 19, 2026 among C.H. Robinson Worldwide, Inc., the lenders party thereto and U.S. Bank National Association, as administrative agent.
10.2
Seventh Amendment to the Receivables Purchase Agreement, dated as of November 18, 2026, by and among C.H. Robinson Receivables, LLC, as seller, C.H. Robinson Worldwide, Inc., as master servicer, Bank of America, N.A., as a committed purchaser, purchaser agent and prior administrative agent, and Wells Fargo Bank, National Association, as a committed purchaser, purchaser agent and successor administrative agent.
10.3
Amended and Restated Performance Guaranty, dated as of November 18, 2026, between C.H. Robinson Worldwide, Inc., as performance guarantor, and Wells Fargo Bank, National Association, as administrative agent.
10.4
Second Amendment to the Receivables Sale Agreement, dated as of November 18, 2026, by and among C.H. Robinson Receivables, LLC, as buyer, C.H. Robinson Worldwide, Inc., as master servicer, and the originators party thereto.
10.5
Sixth Amendment to the Receivables Purchase Agreement, dated as of June 1, 2026, by and among C.H. Robinson Receivables, LLC, as seller, C.H. Robinson Worldwide, Inc., as master servicer and performance guarantor, Bank of America, N.A., as a committed purchaser, purchaser agent and administrative agent, and Wells Fargo Bank, National Association, as a committed purchaser and purchaser agent.
104The cover page from the Current Report on Form 8-K formatted in Inline XBRL
*Certain schedules and exhibits to the Term Loan Agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to furnish supplemental copies of any of the omitted schedules and exhibits upon request by the U.S. Securities and Exchange Commission.




    
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
C.H. ROBINSON WORLDWIDE, INC.
By:/s/ Dorothy G. Capers
Dorothy G. Capers
Chief Legal Officer and Secretary
Date: November 20, 2026


Filing Exhibits & Attachments

8 documents

Keep reading